Table 3.

Endometrial cancer: priorities in outpatient visits and staging

High priority	Medium	Low
Outpatient visits
Potentially unstable (acute abdominal pain, complications in the postsurgery recovery or during/after pelvic RT). Systematic persistent severe bleeding from primary/recurrent tumour. Anuria, symptoms of DVT/PE in patients with confirmed diagnosis of endometrial cancer.	Investigations for postmenopausal bleeding (US, hysteroscopy). Postoperative patients with no complications requiring adjuvant treatment. Established patients with new problems or symptoms from treatment (convert to telemedicine visits as many visits as possible). Follow-up visits in the context of a clinical trial.*	Fertility-preserving therapy in premalignant disease (AH or (EIN)). Follow-up in high-risk patients after primary treatment (postpone up to a maximum of 6 months if no symptoms). Follow-up in intermediate-low-risk patients (covert to telemedicine). Slowly growing asymptomatic vaginal/central recurrence.
Imaging
Bowel perforation, peritonitis. Postsurgery complications (perforation, anastomotic leak, PE, abscess, haemorrhage). Ureteral compression or dislocation with hydronephrosis. Completion of staging workup (eg, CT scan).	Tumour evaluation if clinical suspicion of tumour recurrence after radical treatment. Follow-up visit (clinical and pelvic examination) after palliative treatment for advanced/recurrent disease (postpone up to 2 months). Follow-up visits in the context of a clinical trial* Follow-up visits in the context of fertility-sparing treatment of low-risk endometrial cancer.	Follow-up visits out of study (blood tests and imaging close to home, convert to telemedicine if possible).

*For patients on clinical trials, seek information about changes in management for individual studies from the coordinating trials unit for treatment frequency, blood investigations and imaging.

AH, atypical hyperplasia; DVT, deep vein thrombosis; EIN, endometrial intraepithelial neoplasia; PE, pulmonary embolism; RT, radiotherapy; US, ultrasound.